BioAtla, LLC announced that it will receive $15 million in an equity round of funding from new investor Global BIO Impact Fund, a fund managed by Biotech Investment Group on January 10, 2016. The transaction is expected to completed by the end of January 2016.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.925 USD | +10.00% |
|
+65.75% | -21.17% |
11:02am | Indices: What's small is cute again | ![]() |
Jul. 01 | BioAtla, Inc.(NasdaqGM:BCAB) dropped from Russell 3000E Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.17% | 84.2M | |
+24.72% | 46.56B | |
+45.38% | 41.67B | |
-0.05% | 41.16B | |
+33.16% | 32.4B | |
+20.67% | 28.18B | |
-6.35% | 28.1B | |
+49.40% | 14.52B | |
+47.20% | 13.74B | |
+1.96% | 12.17B |
- Stock Market
- Equities
- BCAB Stock
- News BioAtla, Inc.
- BioAtla, LLC announced that it expects to receive $15 million in funding from Biotech Investment Group.